The Design Driver for Biosimilar Adoption

BioPharm international

Covering all aspects of biopharmaceutical development, analysis, processing, and packaging, BioPharm International, launched in 1988, provides technical and business insight for all biologic-based therapies. As well as covering business strategies and regulatory issues, the print and digital editorial coverage reaches professionals involved in the development and manufacturing of biopharmaceutical therapeutics and diagnostics.

A recent report estimates, that with a substantial increase in the global market opportunity for manufacturers of biosimilars, it is now valued at $3.12 billion per year. Owen Mumford Pharmaceutical Services’ George I’ons, Head of Product Strategy and Insights, discusses the impact of this alongside the crucial consideration of device design.

View Full Article

Get In Touch

    I would like to receive email marketing from Owen Mumford about new products and services Owen Mumford offers.
    I understand that I can find further information about this in the Privacy Policy.